| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.43 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |